Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för PD158780. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

9 träffar

Bibliografisk träff 2016-12-15

Interleukin-6 and neuregulin-1 as regulators of utrophin expression via the activation of NRG-1/ErbB signaling pathway in mdx cells.

Juretić N, Díaz J, Romero F, González G, Jaimovich E, Riveros N.

Biochim Biophys Acta Mol Basis Dis · journal article · DOI 10.1016/j.bbadis.2016.12.008

Bibliografisk träff 2012-02-22

Tyrosine kinase inhibitors influence ABCG2 expression in EGFR-positive MDCK BCRP cells via the PI3K/Akt signaling pathway.

Pick A, Wiese M.

ChemMedChem · journal article · DOI 10.1002/cmdc.201100543

Bibliografisk träff 2006-11-01

An acute effect of neuregulin 1 beta to suppress alpha 7-containing nicotinic acetylcholine receptors in hippocampal interneurons.

Chang Q, Fischbach GD.

J Neurosci · comparative study; research-article; journal article · DOI 10.1523/jneurosci.1794-06.2006

Bibliografisk träff 2005-02-01

G1 cell cycle arrest due to the inhibition of erbB family receptor tyrosine kinases does not require the retinoblastoma protein.

Gonzales AJ, Fry DW.

Exp Cell Res · journal article · DOI 10.1016/j.yexcr.2004.08.040

Bibliografisk träff 2003-03-01

Dissociation of focal adhesion kinase and paxillin tyrosine phosphorylation induced by bombesin and lysophosphatidic acid from epidermal growth factor receptor transactivation in Swiss 3T3 cells.

Salazar EP, Hunger-Glaser I, Rozengurt E.

J Cell Physiol · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1002/jcp.10204

Bibliografisk träff 1999-03-01

Growth inhibition of nasopharyngeal carcinoma cells by EGF receptor tyrosine kinase inhibitors.

Sun Y, Fry DW, Vincent P, Nelson JM, Elliott W, Leopold WR.

Anticancer Res · journal article

Bibliografisk träff 1998-06-01

Role of tyrosine kinase activity of epidermal growth factor receptor in the lysophosphatidic acid-stimulated mitogen-activated protein kinase pathway.

Cunnick JM, Dorsey JF, Standley T, Turkson J, Kraker AJ, Fry DW, Jove R, Wu J.

J Biol Chem · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1074/jbc.273.23.14468

Bibliografisk träff 1998-02-01

Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.

Rewcastle GW, Murray DK, Elliott WL, Fry DW, Howard CT, Nelson JM, Roberts BJ, Vincent PW, Showalter HD, Winters RT, Denny WA.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/jm970641d

Bibliografisk träff 1997-10-01

Biochemical and antiproliferative properties of 4-[ar(alk)ylamino]pyridopyrimidines, a new chemical class of potent and specific epidermal growth factor receptor tyrosine kinase inhibitor.

Fry DW, Nelson JM, Slintak V, Keller PR, Rewcastle GW, Denny WA, Zhou H, Bridges AJ.

Biochem Pharmacol · journal article · DOI 10.1016/s0006-2952(97)00242-6